• 1. Genotype–phenotype modeling considering intermediate level of biological variation: a case study involving sensory traits, metabolites and QTLs in ripe tomatoes
  Huange Wang,Joao Paulo,Willem Kruijer,Martin Boer,Hans Jansen,Yury Tikunov,Bj?rn Usadel,Sjaak van Heusden,Arnaud Bovy,Fred van Eeuwijk Mol. BioSyst. 2015 11 3101
• 2. An insight into key volatile compounds in acerola (Malpighia emarginata DC.) pulp based on their odour activity values and chemometric evaluation
  Juliete Pedreira Nogueira,Airla Carla Pires de Siqueira,Rafael Donizete Dutra Sandes,Mércia de Sousa Galv?o,Maria Terezinha Santos Leite Neta,Narendra Narain Anal. Methods 2018 10 5851
• 3. Quantification of β-damascenone in orange juice using headspace standard addition SPME with selected ion GC-MS
  Kanjana Mahattanatawee,Kevin Goodner,Russell Rouseff Anal. Methods 2013 5 2630
• 4. PLS regression-based chemometric modeling of odorant properties of diverse chemical constituents of black tea and coffee
  Probir Kumar Ojha,Kunal Roy RSC Adv. 2018 8 2293
• 5. Exploration of the reactive modelling of sol–gel polycondensation in the presence of templates
  Manuel Azenha,Borys Szefczyk Soft Matter 2019 15 5770

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Enones
• Natural Products and Extracts Plant Extracts Plant based Tordylium apulum

Chemical Profile of 1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one (CAS No. 23726-93-4)

1-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one, identified by its Chemical Abstracts Service (CAS) number 23726-93-4, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This molecule, characterized by its 2,6,6-trimethylcyclohexa-1,3-dien-1-yl substituent and a conjugated butenone backbone, exhibits unique structural and functional properties that make it a valuable candidate for various applications.

The molecular structure of 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one consists of a rigid trimethylcyclohexadiene moiety linked to a butenone unit. This configuration imparts both steric hindrance and electronic richness to the molecule, facilitating its interaction with biological targets. The presence of multiple double bonds and the conjugation between the cyclohexadiene and butenone moieties contribute to its photophysical properties, making it a potential candidate for applications in photochemistry and optoelectronics.

In recent years, the compound has garnered attention in the pharmaceutical industry due to its structural similarity to natural products known for their bioactivity. Specifically, the 2,6,6-trimethylcyclohexa-1,3-dienyl group is reminiscent of compounds found in certain plant-derived molecules that have demonstrated antimicrobial and anti-inflammatory properties. This has prompted researchers to explore its potential as a lead compound in drug discovery programs targeting inflammatory diseases and infections.

One of the most compelling aspects of 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one is its ability to act as a synthetic intermediate. The conjugated system of double bonds allows for facile functionalization through reactions such as Diels-Alder cycloadditions and cross-coupling reactions. These transformations enable chemists to modify the molecule further, creating libraries of derivatives with tailored biological activities. Such synthetic versatility has made it a popular choice in medicinal chemistry campaigns aimed at developing novel therapeutic agents.

Recent studies have also highlighted the compound's role in materials science. The rigid framework provided by the trimethylcyclohexadiene core enhances thermal stability and mechanical strength when incorporated into polymers or copolymers. Additionally, the extended π-system contributes to electron delocalization, which is advantageous for applications in organic electronics such as light-emitting diodes (OLEDs) and photovoltaic cells. Researchers are investigating its potential as a building block for high-performance materials with improved optoelectronic properties.

The pharmacological potential of 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)but-2-en-1-one has been further explored through computational modeling and experimental screening. Molecular docking studies suggest that the compound can interact with various biological targets, including enzymes and receptors involved in metabolic pathways relevant to neurodegenerative diseases. Preliminary in vitro assays have shown promising results in modulating key signaling pathways associated with inflammation and oxidative stress. These findings underscore its therapeutic relevance and justify further investigation into its pharmacokinetic profile.

In conclusion, 1-(2,6,6-trimethylcyclohexa-1,3-dien-1-y butenone (CAS No. 23726934) stands out as a multifaceted compound with applications spanning organic synthesis, materials science, and pharmaceutical research. Its unique structural features offer opportunities for innovation across multiple disciplines, making it a cornerstone of modern chemical research efforts aimed at addressing complex scientific challenges.

• 514-78-3(canthaxanthin)
• 27185-77-9(2-Cyclohexen-1-one,2,4,4-trimethyl-3-(3-oxo-1-buten-1-yl)-)
• 2607-52-5(2,6-Di-tert-butyl-p-quinomethaneDISCONTINUED)
• 432-68-8(Echinenone (Technical Grade))
• 23696-85-7(Damascenone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)